Metabolic reprogramming and astrocytes polarization following ischemic stroke

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Astrocytes are crucial for neuronal function and become activated (reactive) following ischemic stroke.
• Reactive astrocytes polarize into A1 (neurotoxic) and A2 (neuroprotective) phenotypes, influencing cerebral ischemia/reperfusion (I/R) injury outcomes.
• Metabolic reprogramming, involving changes in pathways like glycolysis and glycogenolysis, is observed in A1 and A2 astrocytes.

Purpose of the Study:

• To review factors affecting astrocytic polarization in cerebral I/R injury.
• To emphasize the role of metabolic reprogramming in reactive astrocytes during I/R injury.
• To explore the link between metabolic reprogramming and astrocytic phenotype switching.

Main Methods:

• Literature review focusing on astrocyte biology, ischemic stroke, and metabolic pathways.
• Analysis of studies investigating astrocytic polarization and metabolic changes.
• Synthesis of evidence linking metabolic reprogramming to A1/A2 astrocyte phenotypes.

Main Results:

• A1 and A2 astrocytes exhibit distinct metabolic profiles, including differences in glycolysis, glutamate uptake, and glycogenolysis.
• Evidence suggests that modulating metabolic homeostasis can shift astrocytes from A1 to A2 phenotype.
• Astrocytic polarization is closely associated with the severity of cerebral I/R injury.

Conclusions:

• Metabolic reprogramming plays a significant role in determining reactive astrocyte phenotype (A1 vs. A2).
• Targeting metabolic pathways in reactive astrocytes presents a promising therapeutic strategy for mitigating cerebral I/R injury.
• Understanding astrocytic metabolic reprogramming is key to developing novel treatments for stroke.